YWHAH (14-3-3 eta) is a multifunctional adapter protein encoded on chromosome 22.1-q13.1 1 that regulates diverse signaling pathways by binding phosphorylated protein partners. Primary functions include modulating kinase activity, particularly negatively regulating PDPK1, and facilitating protein-protein interactions 2. Mechanistically, YWHAH acts as a molecular bridge in multiple pathways: it interacts with YAP to regulate its nuclear translocation in bone homeostasis 2, negatively regulates MAPK/ERK signaling in colorectal cancer cells to suppress autophagy 3, and bridges circEHD2 and YAP for SOX9 activation in renal cell carcinoma 4. Disease relevance is substantial across cancer types. YWHAH is highly expressed in colorectal cancer tissues, correlating with poor differentiation, advanced stage, lymph node metastasis, and unfavorable prognosis 3. It also interacts with gremlin 1, an oncogenic protein overexpressed in multiple cancer types including cervical, lung, kidney, breast, and colon carcinomas 5. Emerging evidence suggests YWHAH may serve as a biomarker for sepsis progression 6 and is implicated in Alzheimer's disease pathology 7. These findings position YWHAH as a critical therapeutic target in cancer and neurodegenerative diseases.